Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
As of December 2025 39.05% is owned by Indian Promoters and 60.94% by Public. Top five Promoters holding highest number of shares of Aarey Drugs & Ph...more...
Certificate under reg 74(5) of SEBI (Depositories and Participants) Regulations 2018more...
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Inside...more...
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publicationmore...
The company reported standalone net profit of Rs 1.02 crore for the quarter ended September 30 2025 as compared to Rs 1.60 crore in the same...more...
Approval of Unaudited Financial results for the quarter & half year ended on 30th Sept 2025more...
Outcome of Board meeting for approval of Unaudited Financial Results for the quarter and half year ended 30th September 2025more...
Aarey Drugs & Pharmaceuticals Limited has submitted to the Exchange the financial results for the period ended September 30 2025.more...
Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter...more...
As of September 2025 44.80% is owned by Indian Promoters and 55.20% by Public. Top five Promoters holding highest number of shares of Aarey Drugs & P...more...
Certificate under regulation 74(5) of SEBI (Depository and Participants) Regulations 2018 for the quarter and half year ended 30th September 2025more...
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018 for qua...more...
Aarey Drugs & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 29 2025more...
Disclosure on Voting Results along with Consolidated Scrutinizers Report of 35th Annual General Meeting of the Companymore...
BOARD MEETINGS Company Name : Action Construction Date : 03-02-2026